Maze Therapeutics, Inc. Common Stock (MAZE)

Maze Therapeutics, Inc. Common Stock (MAZE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.5B; returns 1 day -2.9%, 1 week +12.6%, 1 year +3.7%.

Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company that focuses on developing small molecule precision medicines for kidney and metabolic diseases. The company's strategy involves translating novel genetic insights into new therapies.

Groups MAZE belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Precision Medicine
• Metabolic Disorders
• Nephrology
• Small Business Lending
• Life Sciences
• Rare Diseases
• Drug Discovery

MAZE financial model: income statement, cash flow and balance sheet